You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

  • Product nameAnti-MT-ND1 antibody
  • Description
    Rabbit polyclonal to MT-ND1
  • SpecificityThis antibody detects endogenous levels of total MT-ND1 protein.
  • Tested applicationsWB, ELISA, IHC-P more details
  • Species reactivity
    Reacts with: Mouse, Human, Fruit fly (Drosophila melanogaster)
  • Immunogen

    A synthesized peptide derived from an internal region of human MT-ND1.

  • Positive controlHuman placenta tissue and extracts from Jurkat cells.

Properties

Applications

Our Abpromise guarantee covers the use of ab74257 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
WB WB: 1/500 - 1/1000. Predicted molecular weight: 36 kDa.
ELISA ELISA: 1/40000.
IHC-P IHC-P: 1/50 - 1/100.

Target

  • FunctionCore subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) that is believed to belong to the minimal assembly required for catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone.
  • Involvement in diseaseDefects in MT-ND1 are a cause of Leber hereditary optic neuropathy (LHON) [MIM:535000]. LHON is a maternally inherited disease resulting in acute or subacute loss of central vision, due to optic nerve dysfunction. Cardiac conduction defects and neurological defects have also been described in some patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes.
    Defects in MT-ND1 are a cause of mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome (MELAS) [MIM:540000]. MELAS is a genetically heterogenious disorder, characterized by episodic vomiting, seizures, and recurrent cerebral insults resembling strokes and causing hemiparesis, hemianopsia, or cortical blindness.
    Defects in MT-ND1 may be associated with susceptibility to Alzheimer disease mitochondrial (AD-MT) [MIM:502500]. Alzheimer disease is a neurodegenerative disorder characterized by progressive dementia, loss of cognitive abilities, and deposition of fibrillar amyloid proteins as intraneuronal neurofibrillary tangles, extracellular amyloid plaques and vascular amyloid deposits. The major constituent of these plaques is the neurotoxic amyloid-beta-APP 40-42 peptide (s), derived proteolytically from the transmembrane precursor protein APP by sequential secretase processing. The cytotoxic C-terminal fragments (CTFs) and the caspase-cleaved products such as C31 derived from APP, are also implicated in neuronal death.
    Defects in MT-ND1 may be associated with non-insulin-dependent diabetes mellitus (NIDDM).
  • Sequence similaritiesBelongs to the complex I subunit 1 family.
  • Cellular localizationMitochondrion inner membrane.
  • Target information above from: UniProt accession P03886 The UniProt Consortium
    The Universal Protein Resource (UniProt) in 2010
    Nucleic Acids Res. 38:D142-D148 (2010) .

    Information by UniProt
  • Database links
    • Alternative names
        Mitochondrially encoded NADH dehydrogenase 1 antibodyMT-ND1 antibodyMTND1 antibody
        NAD1 antibodyNADH dehydrogenase subunit 1 (complex I) antibodyNADH dehydrogenase subunit 1 antibodyNADH-ubiquinone oxidoreductase chain 1 antibodyNADH1 antibodyND1 antibodyNU1M_HUMAN antibody
      see all

    Anti-MT-ND1 antibody images

    • All lanes : Anti-MT-ND1 antibody (ab74257) at 1/500 dilution

      Lane 1 : Extracts from Jurkat cells
      Lane 2 : Extracts from Jurkat cells plus 5µg immunizing peptide

      Lysates/proteins at 5 µg per lane.


      Predicted band size : 36 kDa
      Observed band size : 36 kDa
      Additional bands at : 21 kDa,55 kDa. We are unsure as to the identity of these extra bands.
    • Immunohistochemical analysis of MT-ND1 in paraffin embedded human placenta tissue using ab74257 at a 1/50 dilution.
      Left image: untreated.
      Right image: treated with immunizing peptide.
    • All lanes : Anti-MT-ND1 antibody (ab74257) at 1/500 dilution

      Lane 1 : Whole larval extract
      Lane 2 : Whole larval extract
      Lane 3 : Whole larval extract

      Lysates/proteins at 100 µg per lane.

      Secondary
      Donkey polyclonal to Rabbit IgG conjugated to IRDye 800CW at 1/500 dilution
      developed using the ECL technique

      Performed under reducing conditions.

      Predicted band size : 36 kDa


      Exposure time : 5 minutes

      Joseph Bateman, Kings College London, United Kingdom

      See Abreview

    References for Anti-MT-ND1 antibody (ab74257)

    This product has been referenced in:
    • Guo W  et al. Examining the interactome of huperzine A by magnetic biopanning. PLoS One 7:e37098 (2012). WB ; Mouse . Read more (PubMed: 22615909) »
    • Qattan AT  et al. Spatial Distribution of Cellular Function: The Partitioning of Proteins between Mitochondria and the Nucleus in MCF7 Breast Cancer Cells. J Proteome Res : (2012). Read more (PubMed: 23051583) »

    See all 3 Publications for this product

    Product Wall

    Filter by Application

    Filter by Species

    Filter by Ratings

    Application Western blot
    Sample Fruit fly (Drosophila melanogaster) Tissue lysate - whole (Whole larval extract)
    Loading amount 100 µg
    Specification Whole larval extract
    Gel Running Conditions Reduced Denaturing
    Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 21°C
    Username

    Verified customer

    Submitted Oct 19 2012

    Abreviews
    Application Western blot
    Sample Rat Cell lysate - whole cell (NEURONES PRIMAIRES CORTICAUX (primary cortical neu)
    Loading amount 1.2e+006 cells
    Specification NEURONES PRIMAIRES CORTICAUX (primary cortical neu
    Gel Running Conditions Reduced Denaturing (GEL ACRYLAMIDE 14%)
    Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 25°C
    Username

    Verified customer

    Submitted Oct 05 2012

    Application Western blot
    Sample Human Cell lysate - other (HeLa WT vs HeLa rho-0)
    Loading amount 13 µg
    Specification HeLa WT vs HeLa rho-0
    Gel Running Conditions Reduced Denaturing (4-15%)
    Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 23°C
    Username

    Verified customer

    Submitted Jul 06 2012

    Application Western blot
    Sample Mouse Cell lysate - whole cell (L6 and C2C12 muscle cells)
    Loading amount 10 µg
    Specification L6 and C2C12 muscle cells
    Gel Running Conditions Reduced Denaturing (10%)
    Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 10% · Temperature: RT°C
    Username

    Verified customer

    Submitted Jul 28 2010

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"